Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer

被引：0
|
作者：
Hiroki Goya
Hiroshi Kuraishi
Shigeru Koyama
Takashi Ichiyama
Fumiaki Yoshiike
Kazuya Hirai
Toshihiko Agatsuma
Kazunari Tateishi
Shintaro Kanda
Hiroshi Yamamoto
Keishi Kubo
Tomonobu Koizumi
机构：
[1] Nagano Red Cross Hospital,Respiratory Division
[2] Nagano Municipal Hospital,Respiratory Division
[3] Shinshu University School of Medicine,First Department of Internal Medicine
[4] Shinshu University Hospital School of Medicine,Division of Clinical Oncology, Comprehensive Cancer Center
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 70卷
关键词：
Chemo-refractory; Salvage chemotherapy; Second line; CTP-11;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 697
页数：6
相关论文
共 50 条
  • [41] Treatment of advanced non-small cell lung cancer (NSCLC) with a biweekly schedule of irinotecan (I), paclitaxel, and cisplatinum (P): A phase II study
    Gonzalez, M.
    Rebollo, J.
    Rami, R.
    Belda, J.
    Farre, J.
    Azinovic, I.
    Crespo, A.
    Brugarolas, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer
    Takashi Hirose
    Takao Shirai
    Hiroo Ishida
    Kohichi Ando
    Tomohide Sugiyama
    Sojiro Kusumoto
    Takamichi Hosaka
    Masanao Nakashima
    Tohru Ohmori
    Mitsuru Adachi
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 267 - 274
  • [43] Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Kelley, Michael J.
    Jha, Gautam
    Shoemaker, Debra
    Herndon, James E., II
    Gu, Lin
    Barry, William T.
    Crawford, Jeffrey
    Ready, Neal
    CANCER INVESTIGATION, 2017, 35 (01) : 32 - 35
  • [44] Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer
    Hirose, Takashi
    Shirai, Takao
    Ishida, Hiroo
    Ando, Kohichi
    Sugiyama, Tomohide
    Kusumoto, Sojiro
    Hosaka, Takamichi
    Nakashima, Masanao
    Ohmori, Tohru
    Adachi, Mitsuru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (02) : 267 - 274
  • [45] Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601
    Akie, Kenji
    Oizumi, Satoshi
    Ogura, Shigeaki
    Shinagawa, Naofumi
    Kikuchi, Eiki
    Fukumoto, Shinichi
    Harada, Masao
    Kinoshita, Ichiro
    Kojima, Tetsuya
    Harada, Toshiyuki
    Fujita, Yuka
    Ohsaki, Yoshinobu
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ONCOLOGY, 2011, 81 (02) : 84 - 90
  • [46] Phase II study of irinotecan and carboplatin for advanced non-small cell lung cancer
    Takeda, K
    Takifuji, N
    Uejima, H
    Yoshimura, N
    Terakawa, K
    Negoro, S
    LUNG CANCER, 2002, 38 (03) : 303 - 308
  • [47] PHASE I/II TRIAL OF S-1 PLUS DOCETAXEL (DTX) FOR PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): KANTO RESPIRATORY DISEASE STUDY GROUP
    Kasai, Takashi
    Mori, Kiyoshi
    Kobayashi, Kunihiko
    Komiyama, Kenichiro
    Minezaki, Syohei
    Uchida, Yuka
    Hoshi, Eishin
    Koyama, Shinichiro
    Eguchi, Keisuke
    Nakayama, Mitsuo
    Kikuchi, Koji
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1211 - S1212
  • [48] Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer
    M Inokuchi
    T Yamashita
    H Yamada
    K Kojima
    W Ichikawa
    Z Nihei
    T Kawano
    K Sugihara
    British Journal of Cancer, 2006, 94 : 1130 - 1135
  • [49] A phase IINCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer
    Molina, Julian R.
    Nikcevich, Daniel
    Hillman, Shauna
    Geyer, Susan
    Drevyanko, Timothy
    Jett, James
    Verdirame, Joseph
    Tazelaar, Henry
    Rowland, Kendrith
    Wos, Edward
    Kutteh, Leila
    Nair, Suresh
    Fitch, Tom
    Flynn, Patrick
    Stella, Philip
    Adjei, Alex A.
    CANCER INVESTIGATION, 2006, 24 (04) : 382 - 389
  • [50] Phase I/II Trial of Biweekly Nab-Paclitaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer: NJLCG1402
    Tanaka, H.
    Miyauchi, E.
    Nakamura, A.
    Harada, T.
    Nakagawa, T.
    Morita, M.
    Jingu, D.
    Tomoya, K.
    Gamou, S.
    Saito, R.
    Inoue, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S916 - S916
12345